| RECOMMENDATION 7 |
| We recommend that attacks are treated with either intravenous C1 inhibitor, ecallantide, or icatibant. |
| 96% agreement, evidence level A |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.